Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating termination of a Phase 2/Phase 3 trial of letrozole as maintenance therapy for endometrial cancer with NSMP after surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

Sponsor: Fudan University | Conditions: Endometrial Cancer | Phase 2, Phase 3 | Status: TERMINATED